Merck Announces FDA Approval Of An Expanded Indication For Its Pneumococcal Vaccine CAPVAXIVE
Merck Announces FDA Approval Of An Expanded Indication For Its Pneumococcal Vaccine CAPVAXIVE
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day